Patents by Inventor Tien NGHIEM

Tien NGHIEM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220133669
    Abstract: Provided herein are pharmaceutical compositions comprising 15-HETrE and methods of using the same to treat a variety of conditions and disorders.
    Type: Application
    Filed: October 29, 2021
    Publication date: May 5, 2022
    Inventors: John Climax, David Coughlan, Bill Downes, Tien Nghiem, Markus Weissbach, Moayed Hamza
  • Publication number: 20130004575
    Abstract: A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition.
    Type: Application
    Filed: December 30, 2011
    Publication date: January 3, 2013
    Applicant: VALEANT INTERNATIONAL (BARBADOS) SRL
    Inventors: Tien Nghiem, Graham Jackson
  • Publication number: 20090004281
    Abstract: The present invention relates to a multiparticulate osmotic delivery system. The system is a modified release composition suitable for oral administration. The composition includes a core that includes at least one drug in combination with at least one pharmaceutically acceptable excipient. The composition further includes an osmotic subcoat surrounding the core, and a modified release overcoat surrounding the osmotic subcoated core.
    Type: Application
    Filed: June 26, 2007
    Publication date: January 1, 2009
    Applicant: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
    Inventors: Tien Nghiem, Graham JACKSON
  • Publication number: 20080292700
    Abstract: A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition.
    Type: Application
    Filed: August 6, 2008
    Publication date: November 27, 2008
    Applicant: BIOVAIL LABORATORIES
    Inventors: Tien NGHIEM, Graham Jackson